Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / COVID-19 - Page 27

COVID-19

Novavax and EC finalized advance purchase agreement for up to 200 million doses of COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax and EC finalized advance purchase agreement for up to 200 million doses of COVID-19 vaccine

On Aug. 4, 2021, Novavax announced that it had reached an agreement with the European Commission (EC) for…

Read More Novavax and EC finalized advance purchase agreement for up to 200 million doses of COVID-19 vaccineContinue

NEJM published positive phase 3 trial results for REGEN-COV to prevent SARS-CoV-2 infection
Biotechnology | COVID-19

NEJM published positive phase 3 trial results for REGEN-COV to prevent SARS-CoV-2 infection

On Aug. 4, 2021, Regeneron announced that the New England Journal of Medicine (NEJM) had published positive detailed…

Read More NEJM published positive phase 3 trial results for REGEN-COV to prevent SARS-CoV-2 infectionContinue

INOVIO dosed first participant in phase 2 trial for its DNA vaccine against MERS, a Coronavirus Disease
Biotechnology | COVID-19 | Vaccine

INOVIO dosed first participant in phase 2 trial for its DNA vaccine against MERS, a Coronavirus Disease

On Aug. 4, 2021, Inovio Pharma announced that the company had dosed the first Phase 2 trial subject…

Read More INOVIO dosed first participant in phase 2 trial for its DNA vaccine against MERS, a Coronavirus DiseaseContinue

Vanda closed enrollment in ODYSSEY study comparing tradipitant and placebo In COVID-19 pneumonia patients
COVID-19 | Life Science History

Vanda closed enrollment in ODYSSEY study comparing tradipitant and placebo In COVID-19 pneumonia patients

On Aug. 3, 2021, Vanda Pharmaceuticals announced that enrollment had closed in the ODYSSEY study comparing tradipitant and…

Read More Vanda closed enrollment in ODYSSEY study comparing tradipitant and placebo In COVID-19 pneumonia patientsContinue

Illumina donated US $1 Million in sequencing capabilities for COVID-19 genomic surveillance in India
COVID-19 | Diagnostics | Genomics

Illumina donated US $1 Million in sequencing capabilities for COVID-19 genomic surveillance in India

On Aug. 3, 2021, Illumina announced it had donated US $1 million in sequencing capabilities to the Molecular…

Read More Illumina donated US $1 Million in sequencing capabilities for COVID-19 genomic surveillance in IndiaContinue

Lilly and Incyte’s baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
COVID-19 | Life Science History

Lilly and Incyte’s baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation

On Aug. 3, 2021, Eli Lilly and Incyte announced results from an additional cohort of 101 adult patients…

Read More Lilly and Incyte’s baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilationContinue

CytoDyn received clearance from Brazil’s FDA (ANVISA) to commence pivotal phase 3 trial in critically ill COVID-19 patients
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

CytoDyn received clearance from Brazil’s FDA (ANVISA) to commence pivotal phase 3 trial in critically ill COVID-19 patients

On Aug. 3, 2021, CytoDyn announced that Brazil’s regulatory authority ANVISA (Agência Nacional de Vigilância Sanitária) has approved…

Read More CytoDyn received clearance from Brazil’s FDA (ANVISA) to commence pivotal phase 3 trial in critically ill COVID-19 patientsContinue

MPP, WHO, AFRIGEN, BIOVAC, SAMRC and Africa CDC announced LOI for tech transfer hub in South Africa
COVID-19 | Life Science History | Vaccine

MPP, WHO, AFRIGEN, BIOVAC, SAMRC and Africa CDC announced LOI for tech transfer hub in South Africa

On Jul. 30, 2021, the Medicines Patent Pool and the World Health Organization, Afrigen Biologics, the Biologicals and…

Read More MPP, WHO, AFRIGEN, BIOVAC, SAMRC and Africa CDC announced LOI for tech transfer hub in South AfricaContinue

FDA expanded authorized use of REGEN-COVル (casirivimab and imdevimab)
COVID-19 | FDA | Life Science History

FDA expanded authorized use of REGEN-COVル (casirivimab and imdevimab)

On Jul. 30, 2021, Regeneron announced that the FDA had updated the Emergency Use Authorization (EUA) for the…

Read More FDA expanded authorized use of REGEN-COVル (casirivimab and imdevimab)Continue

FDA broadened existing EUA of Lilly and Incyte’s baricitinib in patients hospitalized with COVID-19
COVID-19 | FDA | Therapeutics

FDA broadened existing EUA of Lilly and Incyte’s baricitinib in patients hospitalized with COVID-19

On Jul. 29, 2021, Incyte announced the U.S. Food and Drug Administration (FDA) had broadened the Emergency Use…

Read More FDA broadened existing EUA of Lilly and Incyte’s baricitinib in patients hospitalized with COVID-19Continue

Emergent BioSolutions resumed manufacturing COVID-19 vaccine at Bayview facility
COVID-19 | FDA

Emergent BioSolutions resumed manufacturing COVID-19 vaccine at Bayview facility

On Jul. 29, 2021, Emergent BioSolutions announced that the FDA had begun allowing Emergent’s Bayview manufacturing facility to…

Read More Emergent BioSolutions resumed manufacturing COVID-19 vaccine at Bayview facilityContinue

Cocrystal’s SARS-CoV-2 3CL protease lead CDI-45205 demonstrated broad-spectrum activity against SARS-CoV-2 Delta and Gamma variants
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics

Cocrystal’s SARS-CoV-2 3CL protease lead CDI-45205 demonstrated broad-spectrum activity against SARS-CoV-2 Delta and Gamma variants

On Jul. 29, 2021, Cocrystal Pharma announced that its SARS-CoV-2 3CL protease lead CDI-45205 and several analogs showed…

Read More Cocrystal’s SARS-CoV-2 3CL protease lead CDI-45205 demonstrated broad-spectrum activity against SARS-CoV-2 Delta and Gamma variantsContinue

Second-generation mRNA COVID-19 vaccine candidate, CV2CoV, demonstrated improved immune response and protection in preclinical study
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Second-generation mRNA COVID-19 vaccine candidate, CV2CoV, demonstrated improved immune response and protection in preclinical study

On Jul. 28, 2021, GlaxoSmithKline and Vir Biotechnology announced they had signed a Joint Procurement Agreement with the…

Read More Second-generation mRNA COVID-19 vaccine candidate, CV2CoV, demonstrated improved immune response and protection in preclinical studyContinue

COVID-19 vaccine delivered into nose of research animals reduced nasal virus shedding
COVID-19 | Life Science History | Vaccine

COVID-19 vaccine delivered into nose of research animals reduced nasal virus shedding

On Jul. 27, 2021, the National Institutes of Health announced that the COVID-19 vaccine AZD1222, when delivered into…

Read More COVID-19 vaccine delivered into nose of research animals reduced nasal virus sheddingContinue

The COVID-19 Vaccine
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | FDA | Life Science History | Therapeutics | Vaccine

The COVID-19 Vaccine

Cast of Characters: Donald Trump, President | Mike Pence, Vice President | Anthony S. Fauci, MD, Director, National…

Read More The COVID-19 VaccineContinue

Department of Veterans Affairs mandated COVID-19 vaccines among employees, including facilities staff
COVID-19 | Vaccine

Department of Veterans Affairs mandated COVID-19 vaccines among employees, including facilities staff

On Jul. 26, 2021, the Department of Veterans Affairs (VA) announced that it had mandated COVID-19 vaccines for…

Read More Department of Veterans Affairs mandated COVID-19 vaccines among employees, including facilities staffContinue

Trevena announced first patient enrolled in NIH-funded ACTIV-4 host tissue trial of TRV027 for COVID-19
COVID-19 | Life Science History | NIH

Trevena announced first patient enrolled in NIH-funded ACTIV-4 host tissue trial of TRV027 for COVID-19

On Jul. 26, 2021, Trevena announced that the first COVID-19 patient had been enrolled in the NIH-funded ACTIV-4…

Read More Trevena announced first patient enrolled in NIH-funded ACTIV-4 host tissue trial of TRV027 for COVID-19Continue

COVAX and World Bank accelerated COVID-19 vaccine access for developing countries
COVID-19 | Life Science History | Vaccine

COVAX and World Bank accelerated COVID-19 vaccine access for developing countries

On Jul. 26, 2021, COVAX and the World Bank accelerated COVID-19 vaccine supply for developing countries through a…

Read More COVAX and World Bank accelerated COVID-19 vaccine access for developing countriesContinue

American Medical Association announced support of COVID-19 vaccine mandates for health care workers
COVID-19 | Life Science History | Medicine | Non-Profit Research

American Medical Association announced support of COVID-19 vaccine mandates for health care workers

On Jul. 26, 2021, the American Medical Association (AMA) call for all health care and long-term care employers…

Read More American Medical Association announced support of COVID-19 vaccine mandates for health care workersContinue

American Nurses Association supported mandated COVID-19 vaccinations for nurses and all health care professionals
COVID-19 | Life Science History

American Nurses Association supported mandated COVID-19 vaccinations for nurses and all health care professionals

On Jul. 26, 2021, the American Nurses Association (ANA), representing the interests of the nationメs 4.2 million registered…

Read More American Nurses Association supported mandated COVID-19 vaccinations for nurses and all health care professionalsContinue

COVID-19 vacation Destinations
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine

COVID-19 vacation Destinations

Planning a Summer vacation? Where to go? How about going to one of those large events with tens…

Read More COVID-19 vacation DestinationsContinue

Relief announced that U.S. collaboration had reporteded successful commercial formulation for aviptadil
COVID-19 | Life Science History

Relief announced that U.S. collaboration had reporteded successful commercial formulation for aviptadil

On Jul. 23, 2021, RELIEF THERAPEUTICS announced that the parent company of its collaboration partner, NRx Pharmaceuticals, reported…

Read More Relief announced that U.S. collaboration had reporteded successful commercial formulation for aviptadilContinue

CHMP adopted positive opinion recommending authorization for use of the Moderna COVID-19 vaccine in adolescents in EU
Biotechnology | COVID-19 | Infectious Disease | Vaccine

CHMP adopted positive opinion recommending authorization for use of the Moderna COVID-19 vaccine in adolescents in EU

On Jul. 23, 2021, Moderna announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…

Read More CHMP adopted positive opinion recommending authorization for use of the Moderna COVID-19 vaccine in adolescents in EUContinue

Pfizer and BioNTech to supply U.S. Government with additional 200 million doses of COVID-19 vaccine
COVID-19 | Life Science History

Pfizer and BioNTech to supply U.S. Government with additional 200 million doses of COVID-19 vaccine

On Jul. 23, 2021, Pfizer and BioNTech announced that the U.S. government had purchased an additional 200 million…

Read More Pfizer and BioNTech to supply U.S. Government with additional 200 million doses of COVID-19 vaccineContinue

Humanigenメs partner in South Korea received pproval to conduct phase 1 study of lenzilumab
COVID-19 | Life Science History

Humanigenメs partner in South Korea received pproval to conduct phase 1 study of lenzilumab

On Jul. 21, 2021, Humanigen announced its development and commercialization partners for South Korea and the Philippines, Telcon…

Read More Humanigenメs partner in South Korea received pproval to conduct phase 1 study of lenzilumabContinue

Moderna announced agreement with Taiwan for 20 million doses of Moderna’s COVID-19 Vaccine and variant booster
Biotechnology | COVID-19 | Infectious Disease | Life Science History | Therapeutics | Vaccine

Moderna announced agreement with Taiwan for 20 million doses of Moderna’s COVID-19 Vaccine and variant booster

On Jul. 22, 2021, Moderna announced a new supply agreement with Taiwan for 20 million doses of Moderna’s…

Read More Moderna announced agreement with Taiwan for 20 million doses of Moderna’s COVID-19 Vaccine and variant boosterContinue

Sorrento announced dosing of COVID-19 patients in phase 2 clinical trial for COVIDROPS neutralizing antibody against SARS-CoV-2
COVID-19 | Life Science History

Sorrento announced dosing of COVID-19 patients in phase 2 clinical trial for COVIDROPS neutralizing antibody against SARS-CoV-2

On Jul. 21, 2021, Sorrento Therapeutics announced that COVID-19 patients had been dosed in its Phase 2 efficacy…

Read More Sorrento announced dosing of COVID-19 patients in phase 2 clinical trial for COVIDROPS neutralizing antibody against SARS-CoV-2Continue

Pfizer and BioNTech announced collaboration with Biovac to manufacture and distribute COVID-19 vaccine doses in Africa
COVID-19 | Life Science History | Vaccine

Pfizer and BioNTech announced collaboration with Biovac to manufacture and distribute COVID-19 vaccine doses in Africa

On Jul. 21, 2021, Pfizer and BioNTech announced the signing of a letter of intent with The Biovac…

Read More Pfizer and BioNTech announced collaboration with Biovac to manufacture and distribute COVID-19 vaccine doses in AfricaContinue

Japan became first country to approve Ronapreve (casirivimab and imdevimab) for ttreatment of mild to moderate COVID-19
COVID-19 | Life Science History

Japan became first country to approve Ronapreve (casirivimab and imdevimab) for ttreatment of mild to moderate COVID-19

On Jul. 20, 2021, Roche announced that Japanメs Ministry of Health, Labour and Welfare (MHLW) had approved Ronapreveル(casirivimab…

Read More Japan became first country to approve Ronapreve (casirivimab and imdevimab) for ttreatment of mild to moderate COVID-19Continue

Moderna partnered with Takeda and Government of Japan to aupply additional 50 million doses of COVID-19 vaccine and variant booster candidate
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna partnered with Takeda and Government of Japan to aupply additional 50 million doses of COVID-19 vaccine and variant booster candidate

On Jul. 20, 2021, Moderna announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and…

Read More Moderna partnered with Takeda and Government of Japan to aupply additional 50 million doses of COVID-19 vaccine and variant booster candidateContinue

Page navigation

Previous PagePrevious 1 … 25 26 27 28 29 … 98 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search